Journal Pre-proof Prevalence of post-acute COVID-19 symptoms twelve months after hospitalisation in participants retained in follow-up: analyses stratified by gender from a large prospective cohort

Persistent post-acute COVID-19 symptom (PACS) have been reported up to 6-months (M6) 67 after hospital discharge. Here we assessed, in the longitudinal prospective national French 68 COVID cohort, symptoms that persisted 12-months (M12) after admission for COVID-19. Hospitalized patients with a virologically-confirmed COVID-19 were enrolled. Follow-up was 72 planned until M12 post-admission. Associations between persistence of  3 PACS at M12 and 73 clinical characteristics at admission were assessed through logistic regression according to 74 gender.

[1]  J. Cervilla,et al.  Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes—a multicentre cohort study , 2022, BMC Medicine.

[2]  K. Kwon,et al.  Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea , 2022, BMC Infectious Diseases.

[3]  A. Slooter,et al.  Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19. , 2022, JAMA.

[4]  Janet Diaz,et al.  A clinical case definition of post-COVID-19 condition by a Delphi consensus , 2021, The Lancet Infectious Diseases.

[5]  J. Geddes,et al.  Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19 , 2021, PLoS medicine.

[6]  A. Nath,et al.  Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease , 2021, Brain : a journal of neurology.

[7]  Ting Yu,et al.  1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study , 2021, The Lancet.

[8]  G. Wegener,et al.  Psychiatric and neuropsychiatric sequelae of COVID-19 – A systematic review , 2021, Brain, Behavior, and Immunity.

[9]  I. Guessous,et al.  Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting , 2021, Annals of Internal Medicine.

[10]  C. Chan,et al.  Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19 , 2021, Gut.

[11]  C. Schmidt,et al.  Bidimensional structure and measurement equivalence of the Patient Health Questionnaire-9: sex-sensitive assessment of depressive symptoms in three representative German cohort studies , 2021, BMC Psychiatry.

[12]  F. Mentré,et al.  Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort , 2021, Clinical Microbiology and Infection.

[13]  M. Beutel,et al.  Similarities and Differences of Mental Health in Women and Men: A Systematic Review of Findings in Three Large German Cohorts , 2021, Frontiers in Public Health.

[14]  T. Jafar,et al.  Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: A systematic review and meta-analysis , 2020, PloS one.

[15]  F. Bruyère,et al.  Follow-up of adults with noncritical COVID-19 two months after symptom onset , 2020, Clinical Microbiology and Infection.

[16]  Z. Turan,et al.  Medical Research Council-sumscore: a tool for evaluating muscle weakness in patients with post-intensive care syndrome , 2020, Critical Care.

[17]  Jordan J. Clark,et al.  Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score , 2020, BMJ.